Details Basic Details Date Tuesday, September 22, 2020 Type Presentation Materials Comparative Risk Assessment of Severe Abnormal Uterine Bleeding associated with Non-Vitamin K Oral Anticoagulants Additional Information Information Host 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Propensity Score Analysis ICPE All Access Conference Abstracts Sentinel Drug Study: Eliquis (Apixaban), Pradaxa (Dabigatran), and Xarelto (Rivaroxaban) & Severe Uterine Bleed Contributors Presenter(s) Efe Eworuke, Laura Hou, Rongmei Zhang, Hui-Lee Wong, Peter Waldron, Abby Anderson, Audrey Gassman, David Moeny, Ting-Ying Huang